Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease

Circulation Journal

Volumn 73, Issue 7, 2009, Pages 1319-1323

  Suda, Kenji ^a   Kudo, Yoshiyuki ^a   Higaki, Takashi ^b   Nomura, Yuichi ^c   Miura, Masaru ^d   Matsumura, Masahiko ^e   Ayusawa, Mamoru ^f   Ogawa, Shunichi ^g   Matsuishi, Toyojiro ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d Kiyose Children's Hospital   (Japan)

^e TENRI HOSPITAL   (Japan)

^f NIHON UNIVERSITY   (Japan)

^g NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Anticoagulants; Antiplatelets; Coronary artery disease; Kawasaki disease; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUCOLOME; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; FRESH FROZEN PLASMA; PROTHROMBIN; TICLOPIDINE; TISSUE PLASMINOGEN ACTIVATOR; VITAMIN K GROUP; WARFARIN;

ACUTE HEART INFARCTION; ADD ON THERAPY; ADOLESCENT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CASE STUDY; CHILD; CORONARY ARTERY ANEURYSM; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; DEATH; DRUG WITHDRAWAL; EPIDURAL HEMATOMA; EPISTAXIS; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GINGIVA BLEEDING; HEMATOMA; HUMAN; INFANT; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; OBSERVATIONAL STUDY; OVARIAN BLEEDING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRESCHOOL CHILD; PROGNOSIS; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SCHOOL CHILD; SUBDURAL HEMATOMA; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT DURATION;

ADMINISTRATION, ORAL; ADOLESCENT; ANTICOAGULANTS; ASPIRIN; CHILD; CHILD, PRESCHOOL; CORONARY ANEURYSM; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 68249126595     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0931     Document Type: Article

References (17)

1. Yanagawa H, Nakamura Y, Yashiro M, Uehara R, Oki I, Kayaba K. Incidence of Kawasaki disease in Japan: The nationwide surveys of 1999-2002. Pediatr Int 2006; 48: 356-361.
2. Newburger JW, Fulton DR. Kawasaki disease. Curr Opin Pediatr 2004; 16: 508-514.
3. Fukuzawa R, Igeam E, Watanabe M, Hajikano M, Kamisago M, Katsube Y, et al. Coronary artery aneurysm induced by Kawasaki disease in children show features typical senescence. Circ J 2007; 71: 709-715. (Pubitemid 46683362)
4. Nakamura Y, Aso E, Yashiro M, Uehara R, Watanabe M, Oki I, et al. Mortality among persons with a history of Kawasaki disease in Japan: Mortality among males with cardiac sequelae is significantly higher than that of general population. Circ J 2008; 72: 134-138.
5. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease: A 10- to 21-year follow-up study of 594 patients. Circulation 1996; 94: 1379-1385. (Pubitemid 26307269)
6. Onouchi Z, Hamaoka K, Sakata K, Ozawa S, Shiraishi I, Itoi T, et al. Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: Comparison of therapeutic regimens. Circ J 2005; 69: 265-272. (Pubitemid 40410179)
7. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Surgery and Anesthesia; Quality of Care and Outcomes Research Interdisciplinary Working Group. Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116: 1736-1754.
8. Japanese Circulation Society Joint Research Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease. Pediatr Int 2005; 47: 711-732.
9. van Doom C, Yates R, Tsang V, de Levai M, Elliott M. Mitral valve replacement in children: Mortality, morbidity, and haemodynamic status up to medium term follow up. Heart 2000; 84: 636-642.
10. Streif ByW, Andrew M, Marzinotto V, Massicotte P, Chan AKC, Julian JA, et al. Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. Blood 1999; 94: 3007-3014. (Pubitemid 29512704)
11. Bonduel MM. Oral anticoagulation therapy in children. Thromb Res 2006; 118: 85-94.
12. Sugahara Y, Ishii M, Muta H, Iemura M, Matsuishi T, Kato H. Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease. Pediatr Cardiol 2008; 29: 398-401.
13. Levy DM, Silverman ED, Massicotte P, McCrindle BW, Yeung RSM. Long term outcomes in patients with giant aneurysms secondary to Kawasaki disease. J Rheumatol 2005; 32: 928-934.
14. Ikuma H, Wada H, Mori Y. Hemostatic markers in Japanese patients undergoing anticoagulant therapy under thrombotest monitoring. Blood Coagul Fibrinol 1999; 19: 1-6. (Pubitemid 30002001)
15. Sakai M, Asayama K, Otabe T, Kohri T, Shirahata A. Low tissue plasminogen activator relation to plasminogen activator inhibitor-1 as a maker of cardiac complication in children with Kawasaki disease. Clin Appl Thromb Hemost 2001; 7: 214-218. (Pubitemid 32574183)
16. Pucchi A, Martino S, Celeste A, Linari A, Tibaldi M, Camosso E, et al. Angiogenesis, tumor necrosis factor-α and procoagulant factors in coronary artery giant aneurysm of a fatal infantile Kawasaki disease. Cardiovasc Pathol 2008; 17: 186-189.
17. Doom Cv, Yates R, Tsang V, deLeval M, Elliot M. Mitral valve replacement in children: Mortality, morbidity, and haemodynamic status up to medium term follow up. Heart 2000; 84: 636-642.